Researchers from EKB Technology - a spinout joint venture between the University of Oxford and C-Tech Innovation - have announced positive results from an elegant method of improving mammalian cell bioreactors. Bioreactors are used to manufacture proteins for medicines, and the researchers have show that a mild electric field can successfully extract unwanted by-product chemicals from the bioreactor.